Analyst Consensus ?
ConsensusBuy31 ratings
Bullish2580.6%
Neutral619.4%
Bearish00.0%
FN2 Earnings Intelligence
McKesson Corporation (MCK) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Buy | Buy | Maintain | Jul 24, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 21, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jun 10, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 12, 2026 |
| UBS | Buy | Buy | Maintain | May 8, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 8, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 8, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 6, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Feb 5, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 6, 2025 |
| Baird | Outperform | Outperform | Maintain | Nov 6, 2025 |
| Jefferies | Buy | Buy | Maintain | Oct 14, 2025 |
| Leerink Partners | Outperform | Outperform | Maintain | Sep 24, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 24, 2025 |
| Argus Research | Buy | Buy | Maintain | Jun 24, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 11, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Apr 18, 2022 |
| Goldman Sachs | Buy | Buy | Maintain | May 7, 2021 |
| Guggenheim | Buy | Buy | Maintain | May 27, 2020 |
| CFRA | Buy | Buy | Maintain | May 20, 2020 |
| Standpoint Research | Buy | Hold | Upgrade | Jul 10, 2018 |
| Leerink Swann | Market Perform | Market Perform | Maintain | May 29, 2018 |
| Bank of America | Buy | Buy | Maintain | Apr 11, 2018 |
| RBC Capital | Perform | Sector Perform | Maintain | Sep 19, 2017 |
| Needham | Hold | Hold | Maintain | Apr 4, 2017 |
| Avondale Partners | Market Outperform | Market Perform | Upgrade | Jan 18, 2017 |
| Raymond James | Market Perform | Outperform | Downgrade | Jan 12, 2016 |
| S&P Capital IQ | Buy | Strong Buy | Downgrade | Jan 13, 2014 |
| FBR Capital | Outperform | Outperform | Maintain | Oct 29, 2013 |
| ISI Group | Strong Buy | Buy | Upgrade | Oct 24, 2013 |
| Sterne Agee | Buy | Buy | Maintain | Sep 18, 2013 |
Upside is calculated against the persisted current price $889.5. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Kevin Caliendo | $1,050 | $744.46 | +18.0% | May 8, 2026 |
| Deutsche Bank | George Hill | $875 | $763.9 | -1.6% | May 8, 2026 |
| Raymond James | Analyst unavailable | $970 | $930.31 | +9.1% | Mar 5, 2026 |
| Leerink Partners | Michael Cherny | $1,085 | $930.22 | +22.0% | Mar 5, 2026 |
| Barclays | Analyst unavailable | $1,050 | $946.47 | +18.0% | Feb 18, 2026 |
| Morgan Stanley | Analyst unavailable | $966 | $826.62 | +8.6% | Jan 29, 2026 |
| Robert W. Baird | Eric Coldwell | $968 | $833.36 | +8.8% | Jan 14, 2026 |
| Barclays | Analyst unavailable | $960 | $797.93 | +7.9% | Dec 8, 2025 |
| Evercore ISI | Analyst unavailable | $1,000 | $852.02 | +12.4% | Nov 6, 2025 |
| UBS | Kevin Caliendo | $920 | $801.3 | +3.4% | Oct 27, 2025 |
| Jefferies | Analyst unavailable | $900 | $769.49 | +1.2% | Oct 13, 2025 |
| Wells Fargo | Stephen Baxter | $772 | $659.01 | -13.2% | Aug 13, 2025 |
| Wells Fargo | Stephen Baxter | $766 | $714.88 | -13.9% | Jun 3, 2025 |
| Jefferies | Rob Dickerson | $715 | $541.15 | -19.6% | Nov 19, 2024 |
| Robert W. Baird | Eric Coldwell | $688 | $526.54 | -22.7% | Nov 7, 2024 |
| Deutsche Bank | George Hill | $579 | $479.16 | -34.9% | Sep 25, 2024 |
| Robert W. Baird | Eric Coldwell | $531 | $505 | -40.3% | Sep 24, 2024 |
| Wells Fargo | Stephen Baxter | $535 | $511.17 | -39.9% | Sep 13, 2024 |
| Leerink Partners | Michael Cherny | $665 | $514.75 | -25.2% | Sep 6, 2024 |
| Bank of America Securities | Michael Cherny | $635 | $526.5 | -28.6% | Sep 5, 2024 |
| Mizuho Securities | Ann Hynes | $570 | $617.51 | -35.9% | Aug 8, 2024 |
| Robert W. Baird | Eric Coldwell | $694 | $589.53 | -22.0% | Jul 9, 2024 |
| Argus Research | David Toung | $670 | $608.72 | -24.7% | Jun 24, 2024 |
| Robert W. Baird | Eric Coldwell | $679 | $549.26 | -23.7% | May 29, 2024 |
| Argus Research | David Toung | $570 | $527.28 | -35.9% | Apr 10, 2024 |
| Robert W. Baird | Eric Coldwell | $603 | $534.79 | -32.2% | Apr 5, 2024 |
| Robert W. Baird | Eric Coldwell | $567 | $494.01 | -36.3% | Feb 8, 2024 |
| Argus Research | David Toung | $480 | $515.03 | -46.0% | Feb 7, 2024 |
| Morgan Stanley | Analyst unavailable | $426 | $370.98 | -52.1% | Feb 2, 2023 |
| Morgan Stanley | Analyst unavailable | $420 | $384.01 | -52.8% | Jan 6, 2023 |
| UBS | Kevin Caliendo | $380 | $322.86 | -57.3% | May 23, 2022 |
| Morgan Stanley | Ricky Goldwasser | $370 | $323.25 | -58.4% | Apr 16, 2022 |
| Robert W. Baird | Eric Coldwell | $340 | $258.02 | -61.8% | Feb 2, 2022 |
| Morgan Stanley | Ricky Goldwasser | $292 | $232.69 | -67.2% | Dec 17, 2021 |
| Barclays | Steven Valiquette | $290 | $230.35 | -67.4% | Dec 9, 2021 |
| Argus Research | David Toung | $270 | $219.39 | -69.6% | Nov 8, 2021 |
| Goldman Sachs | Robert Jones | $257 | $195.97 | -71.1% | May 7, 2021 |
Track every rating change on MCK the moment it posts. Free to start.
Start free